MedTrace Logo

Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery

NCT04490668 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1049

Last updated 2020-07-29

No results posted yet for this study

Summary

We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.

Conditions

Interventions

BIOLOGICAL

Human albumin

Patients received intravenous human albumin after gastric cancer surgery. Overall quantity of human albumin were recorded.

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Birendra K Sah, PH D · Ruijin Hospital

  • Chen Li, PH D · Ruijin Hospital

  • Zhenggang Zhu, PH D · Ruijin Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-07-31
Completion
2019-12-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04490668 on ClinicalTrials.gov